
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Polydrug use and polydrug markets amongst image and performance enhancing drug users: Implications for harm reduction interventions and drug policy
Mike Salinas, William Floodgate, Robert Ralphs
International Journal of Drug Policy (2019) Vol. 67, pp. 43-51
Open Access | Times Cited: 49
Mike Salinas, William Floodgate, Robert Ralphs
International Journal of Drug Policy (2019) Vol. 67, pp. 43-51
Open Access | Times Cited: 49
Showing 1-25 of 49 citing articles:
Beyond the law: Exploring the impact of criminalising anabolic–androgenic steroid use on help-seeking and health outcomes in Australia
Timothy Piatkowski, Nick Gibbs, Matthew Dunn
Journal of Criminology (2023) Vol. 57, Iss. 1, pp. 62-82
Open Access | Times Cited: 31
Timothy Piatkowski, Nick Gibbs, Matthew Dunn
Journal of Criminology (2023) Vol. 57, Iss. 1, pp. 62-82
Open Access | Times Cited: 31
“Emerging anabolic androgenic steroid markets; the prominence of social media”
Luke Cox, Nick Gibbs, Luke A. Turnock
Drugs Education Prevention and Policy (2023) Vol. 31, Iss. 2, pp. 257-270
Closed Access | Times Cited: 29
Luke Cox, Nick Gibbs, Luke A. Turnock
Drugs Education Prevention and Policy (2023) Vol. 31, Iss. 2, pp. 257-270
Closed Access | Times Cited: 29
Anabolic-androgenic steroid administration increases self-reported aggression in healthy males: a systematic review and meta-analysis of experimental studies
Razieh Chegeni, Ståle Pallesen, Jim McVeigh, et al.
Psychopharmacology (2021) Vol. 238, Iss. 7, pp. 1911-1922
Open Access | Times Cited: 41
Razieh Chegeni, Ståle Pallesen, Jim McVeigh, et al.
Psychopharmacology (2021) Vol. 238, Iss. 7, pp. 1911-1922
Open Access | Times Cited: 41
Anabolics coaching: Emic harm reduction or a public health concern?
Nick Gibbs, Luke Cox, Luke A. Turnock
Performance Enhancement & Health (2022) Vol. 10, Iss. 3, pp. 100227-100227
Open Access | Times Cited: 35
Nick Gibbs, Luke Cox, Luke A. Turnock
Performance Enhancement & Health (2022) Vol. 10, Iss. 3, pp. 100227-100227
Open Access | Times Cited: 35
Polysubstance use practices among women using anabolic-androgenic steroids (AAS)
Timothy Piatkowski, Jonathan Robertson, Matthew Dunn
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100248-100248
Closed Access | Times Cited: 18
Timothy Piatkowski, Jonathan Robertson, Matthew Dunn
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100248-100248
Closed Access | Times Cited: 18
#Sponseredathlete: the marketing of image and performance enhancing drugs on Facebook and Instagram
Nick Gibbs
Trends in Organized Crime (2023)
Open Access | Times Cited: 18
Nick Gibbs
Trends in Organized Crime (2023)
Open Access | Times Cited: 18
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 18
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 18
“Yay, Another Lady Starting a Log!”: Women’s Fitness Doping and the Gendered Space of an Online Doping Forum
April Henning, Jesper Andreasson
Communication & Sport (2019) Vol. 9, Iss. 6, pp. 988-1007
Open Access | Times Cited: 49
April Henning, Jesper Andreasson
Communication & Sport (2019) Vol. 9, Iss. 6, pp. 988-1007
Open Access | Times Cited: 49
Treatments for people who use anabolic androgenic steroids: a scoping review
Geoff Bates, Marie Claire Van Hout, Joseph Tay Wee Teck, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 43
Geoff Bates, Marie Claire Van Hout, Joseph Tay Wee Teck, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 43
Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway
Morgan Scarth, Ingrid Amalia Havnes, Marie Lindvik Jørstad, et al.
Drug and Alcohol Dependence (2022) Vol. 231, pp. 109275-109275
Open Access | Times Cited: 22
Morgan Scarth, Ingrid Amalia Havnes, Marie Lindvik Jørstad, et al.
Drug and Alcohol Dependence (2022) Vol. 231, pp. 109275-109275
Open Access | Times Cited: 22
Virtuous drug use in the neoliberal age
Caroline Chatwin, Richard Alexander
Drugs Education Prevention and Policy (2025), pp. 1-9
Open Access
Caroline Chatwin, Richard Alexander
Drugs Education Prevention and Policy (2025), pp. 1-9
Open Access
If you find me on the floor, stick some sugar in my mouth : The social production (and protection) of insulin risk among IPED communities
Kim Akrigg, Luke Cox, Luke A. Turnock, et al.
Drugs Education Prevention and Policy (2025), pp. 1-12
Open Access
Kim Akrigg, Luke Cox, Luke A. Turnock, et al.
Drugs Education Prevention and Policy (2025), pp. 1-12
Open Access
The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Jim McVeigh, et al.
Substance Abuse Research and Treatment (2020) Vol. 14
Open Access | Times Cited: 36
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Jim McVeigh, et al.
Substance Abuse Research and Treatment (2020) Vol. 14
Open Access | Times Cited: 36
Steroid and illicit drug abuse in the health and fitness community: A systematic review of evidence
Abdullah Al Hamid, Latifah Alomani, Alhanoof Aljuresan, et al.
Emerging Trends in Drugs Addictions and Health (2025) Vol. 5, pp. 100172-100172
Closed Access
Abdullah Al Hamid, Latifah Alomani, Alhanoof Aljuresan, et al.
Emerging Trends in Drugs Addictions and Health (2025) Vol. 5, pp. 100172-100172
Closed Access
Preventing, producing, or reducing harm? Fitness doping risk and enabling environments
April Henning, Jesper Andreasson
Drugs Education Prevention and Policy (2020) Vol. 29, Iss. 1, pp. 95-104
Open Access | Times Cited: 30
April Henning, Jesper Andreasson
Drugs Education Prevention and Policy (2020) Vol. 29, Iss. 1, pp. 95-104
Open Access | Times Cited: 30
Post‐industrial masculinities and gym culture: Graft, craft, and fraternity
Nick Gibbs, Mike Salinas, Luke A. Turnock
British Journal of Sociology (2021) Vol. 73, Iss. 1, pp. 220-236
Open Access | Times Cited: 25
Nick Gibbs, Mike Salinas, Luke A. Turnock
British Journal of Sociology (2021) Vol. 73, Iss. 1, pp. 220-236
Open Access | Times Cited: 25
Exploring the Impacts of Rurality on Service Access and Harm Among Image and Performance Enhancing Drug (IPED) Users in a Remote English Region
Luke A. Turnock, Kyle Mulrooney
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 232-253
Open Access | Times Cited: 10
Luke A. Turnock, Kyle Mulrooney
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 232-253
Open Access | Times Cited: 10
Support for non-prescribed anabolic androgenic steroids users: a qualitative exploration of their needs
Orlanda Harvey, Margarete Parrish, Edwin van Teijlingen, et al.
Drugs Education Prevention and Policy (2020) Vol. 27, Iss. 5, pp. 377-386
Open Access | Times Cited: 26
Orlanda Harvey, Margarete Parrish, Edwin van Teijlingen, et al.
Drugs Education Prevention and Policy (2020) Vol. 27, Iss. 5, pp. 377-386
Open Access | Times Cited: 26
Rethinking enhancement substance use: A critical discourse studies approach
Rebecca Askew, Lisa Williams
International Journal of Drug Policy (2020) Vol. 95, pp. 102994-102994
Open Access | Times Cited: 26
Rebecca Askew, Lisa Williams
International Journal of Drug Policy (2020) Vol. 95, pp. 102994-102994
Open Access | Times Cited: 26
Social media markets for prescription drugs: platforms as virtual mortars for drug types and dealers
Jakob Demant, Silje Anderdal Bakken, Alexandra Hall
Drugs and Alcohol Today (2020) Vol. 20, Iss. 1, pp. 36-49
Open Access | Times Cited: 21
Jakob Demant, Silje Anderdal Bakken, Alexandra Hall
Drugs and Alcohol Today (2020) Vol. 20, Iss. 1, pp. 36-49
Open Access | Times Cited: 21
Financial risk management strategies of small to medium illicit drug enterprises: considering low-level money laundering
Mark Berry, Mike Salinas, R. V. Gundur
Trends in Organized Crime (2023)
Open Access | Times Cited: 7
Mark Berry, Mike Salinas, R. V. Gundur
Trends in Organized Crime (2023)
Open Access | Times Cited: 7
An overview on performance and image enhancing drugs (PIEDs) confiscated in Italy in the period 2017–2019
Sara Odoardi, Serena Mestria, Giulia Biosa, et al.
Clinical Toxicology (2020) Vol. 59, Iss. 1, pp. 47-52
Closed Access | Times Cited: 19
Sara Odoardi, Serena Mestria, Giulia Biosa, et al.
Clinical Toxicology (2020) Vol. 59, Iss. 1, pp. 47-52
Closed Access | Times Cited: 19
Polydrug use and drug market intersections within powerlifting cultures in remote South-West England
Luke A. Turnock
Performance Enhancement & Health (2021) Vol. 8, Iss. 4, pp. 100186-100186
Closed Access | Times Cited: 17
Luke A. Turnock
Performance Enhancement & Health (2021) Vol. 8, Iss. 4, pp. 100186-100186
Closed Access | Times Cited: 17
Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway
Morgan Scarth, Ingrid Amalia Havnes, Marie Lindvik Jørstad, et al.
(2021)
Open Access | Times Cited: 17
Morgan Scarth, Ingrid Amalia Havnes, Marie Lindvik Jørstad, et al.
(2021)
Open Access | Times Cited: 17
Generating evidence on the use of Image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network
Jim McVeigh, Evelyn Hearne, Ian D. Boardley, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Jim McVeigh, Evelyn Hearne, Ian D. Boardley, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 16